Article Sidebar
Published:
Jun 24, 2021Keywords:
Article Details
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.
Main Article Content
Conjugated linoleic acid attenuates neuropathic pain induced by sciatic nerve in mice
Abstract
Purpose: Conjugated linoleic acid (CLA) has been suggested to be necessary for human health, but there is limited research regarding its effect on neuropathic pain (NP). Here, we aim to investigate the potential effect of CLA administration on NP development and nerve recovery.
Methods: Forty mice were divided into four equal groups randomly. The mice in control group underwent a sham operation to achieve a unilateral sciatic nerve cut. Other groups were subjected to partial sciatic nerve ligation (PSNL) surgery followed by 4 weeks of CLA treatment. Behavioral tests were performed shortly before mice were sacrificed. Blood, sciatic nerve and spinal cord tissues were collected after sacrifice. Electron microscopy was performed to determine myelin thickness and calculate myelin thickness/axon diameter ratio.
Results: Mice that received daily oral CLA treatment for 4 weeks after PSNL surgery showed less mechanical and thermal allodynia than mice in PSNL surgery alone group. Behavioral tests showed that CLA treatment was associated with marked increases in both nerve conduction velocity (NCV) and force of gastrocnemius contraction. In addition, CLA reduced the levels of interleukin-1β (IL-1β) and tumor necrosis factor-α (TNF-α), sciatic myeloperoxidase (MPO) activity, and activating transcription factor-3 (ATF-3) expression. CLA also restored mitochondrial manganese superoxide dismutase (MnSOD) activity which was decreased in the sciatic nerves and spinal cords of the PSNL surgery group. Regeneration of myelins and axons in nerve fibers in CLA group was faster and more complete than that in the vehicle group.
Conclusion: The current study demonstrates that CLA effectively attenuates NP and significantly inhibits neuro-inflammation and oxidative stress. This treatment improves sciatic nerve form and function after injury, suggesting that it can attenuate NP.
